©istock.com/Andrea Obzerova
Interdisziplinäre KompetenzMolekulare Diagnostik
Know how bei der Analyse von Erbmaterial.
Zum Wohle von Patienten.

ErkrankungParoxysmale nicht-kinesiogene Dyskinesie, Differentialdiagnose

Zusammenfassung

Kurzinformation

Umfassendes differentialdiagnostisches panel für Paroxysmale nicht-kinesiogene Dyskinesie, Differentialdiagnose, mit 2 Leitlinien-kuratierten und zusammen genommen 34 kuratierten Genen gemäß klinischer Verdachtsdiagnose

ID
PP9238
Anzahl Gene
18 Akkreditierte Untersuchung
Untersuchte Sequenzlänge
9,3 kb (Core-/Basis-Gene)
36,0 kb (Erweitertes Panel)
Analyse-Dauer
auf Anfrage
Material
  • EDTA-Blut (3-5 ml)
Diagnostische Hinweise

NGS +

 

Genpanel

Ausgewählte Gene

NameExon-Länge (bp)OMIM-GErbgang
ADCY53786AD und/oder AR
KCNMA13537AD und/oder AR
PNKD429AD
SLC2A11479AD und/oder AR
ATP1A33042AD
CHRNA21590AD
CHRNA41884AD
CHRNB21509AD
CRH591Mult und/oder SMu
DEPDC54812AD
DLAT1944AR
KCNT13708AD
LIAS990AR
NKX2-11206AD
PDHA11173XLD
PDHB1080AR
PDHX1506AR
PDP11689AR

Infos zur Erkrankung

Synonyme
  • Alias: Familial Paroxysmal Nonkinesigenic Dyskinesia
  • Alias: Paroxysmal Dystonic Choreoathetosis
  • Alias: Paroxysmal Nonkinesigenic Dyskinesia
  • Alias: Paroxysmale nicht-kinesiogene Choreoathetose
  • Alias: Paroxystic non-kinesigenic choreoathetosis
  • Allelic: Deafness, AD 65 (TBC1D24)
  • Allelic: Deafness, AR 86 (TBC1D24)
  • Allelic: Fetal akinesia, respiratory insuff., microcephaly, polymicrogyria, dysmorphic face (ATP1A)
  • Allelic: Nicotine addiction, susceptibility to (CHRNA4)
  • Alternating hemiplegia of childhood 1 (ATP1A2)
  • Alternating hemiplegia of childhood 2 (ATP1A3)
  • Basal ganglia calcification, idiopathic, 1 (SLC20A2)
  • CAPOS syndrome (ATP1A3)
  • Cerebellar atrophy, developmental delay + seizures (KCNMA1)
  • Charcot-Marie-Tooth disease, XLD, 6 (PDK3)
  • Chorea, hereditary benign (NKX2-1)
  • Choreoathetosis, hypothyroidism + neonatal respiratory distress (NKX2-1)
  • Cognitive impairment with/-out cerebellar ataxia (SCN8A)
  • Convulsions, familial infantile, with paroxysmal choreoathetosis (PRRT2)
  • DOORS syndrome (TBC1D24)
  • Developmental + epileptic encephalopathy 13 (SCN8A)
  • Developmental + epileptic encephalopathy 16 (TBC1D24)
  • Developmental + epileptic encephalopathy 17 (GNAO1)
  • Developmental + epileptic encephalopathy 42 (CACNA1A)
  • Developmental + epileptic encephalopathy 64 (RHOBTB2)
  • Developmental + epileptic encephalopathy 98 (ATP1A2)
  • Dihydrolipoamide dehydrogenase deficiency (DLD)
  • Dyskinesia, familial, with facial myokymia (ADCY5)
  • Dystonia 9 (SLC2A1)
  • Dystonia, DOPA-responsive, with/-out hyperphenylalaninemia (GCH1)
  • Dystonia-12 (ATP1A3)
  • Epilepsy, familial focal, with variable foci 1 (DEPDC5)
  • Epilepsy, idiopathic generalized, susceptibility to, 12 (SLC2A1)
  • Epilepsy, idiopathic generalized, susceptibility to, 16 (KCNMA1)
  • Epilepsy, nocturnal frontal lobe, 1 (CHRNA4)
  • Epilepsy, nocturnal frontal lobe, 3 (CHRNB2)
  • Epilepsy, nocturnal frontal lobe, type 4 (CHRNA2)
  • Epilepsy, rolandic, with proxysmal exercise-induce dystonia + writer's cramp (TBC1D24)
  • Episodic ataxia, type 2 (CACNA1A)
  • Episodic kinesigenic dyskinesia 1 (PRRT2)
  • GLUT1 deficiency syndrome 1, infantile onset, severe (SLC2A1)
  • GLUT1 deficiency syndrome 2, childhood onset (SLC2A1)
  • Glycine encephalopathy (GLDC)
  • Hyperglycinemia, lactic acidosis + seizures (LIAS)
  • Hyperphenylalaninemia, BH4-deficient, B (GCH1)
  • Intellectual developmental disorder with paroxysmal dyskinesia or seizures (PDE2A)
  • Lacticacidemia due to PDX1 deficiency (PDHX)
  • Liang-Wang syndrome (KCNMA1)
  • Migraine, familial basilar (ATP1A2)
  • Migraine, familial hemiplegic, 1 (CACNA1A)
  • Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia (CACNA1A)
  • Migraine, familial hemiplegic, 2 (ATP1A2)
  • Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency (ECHS1)
  • Myoclonic epilepsy, infantile, familial (TBC1D24)
  • Myoclonus, familial, 2 (SCN8A)
  • Neurodevelopmental disorder with involuntary movements (GNAO1)
  • Parkinson disease, juvenile, type 2 (PRKN)
  • Paroxysmal nonkinesigenic dyskinesia 1 (PNKD)
  • Paroxysmal nonkinesigenic dyskinesia, 3, with/-out generalized epilepsy (KCNMA1)
  • Pyruvate dehydrogenase E1-alpha deficiency (PDHA1)
  • Pyruvate dehydrogenase E1-beta deficiency (PDHB)
  • Pyruvate dehydrogenase E2 deficiency (DLAT)
  • Pyruvate dehydrogenase phosphatase deficiency (PDP1)
  • Seizures, benign familial infantile, 2 (PRRT2)
  • Seizures, benign familial infantile, 5 (SCN8A)
  • Spinocerebellar ataxia 27 (FGF14)
  • Spinocerebellar ataxia 6 (CACNA1A)
  • Stomatin-deficient cryohydrocytosis with neurologic defects (SLC2A1)
Erbgänge, Vererbungsmuster etc.
  • AD
  • AD und/oder AR
  • AR
  • Mult und/oder SMu
  • XLD
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code
G24.8

Bioinformatik und klinische Interpretation

Kein Text hinterlegt